Research Hub · Photobiomodulation

Photobiomodulation: The Cytochrome c Oxidase Story

A complete reference hub for the photobiomodulation (PBM) mechanism domain that grounds the photonic half of the Tesla BioLights S.E.A.D. System. Cytochrome c oxidase as a light-absorbing chromophore. The 600-1100 nm optical window. FDA clearance across multiple indications. The Karu and Hamblin mechanism literature. The anti-inflammatory, mitochondrial, and bioenergetic pathways. Eight peer-reviewed Journal essays, synthesized.

What photobiomodulation is

Photobiomodulation (PBM) — historically called low-level laser therapy (LLLT) or cold laser therapy — is the therapeutic use of red and near-infrared light at wavelengths between approximately 600 and 1100 nanometers to modulate cellular processes through the absorption of photons by mitochondrial cytochrome c oxidase. The mechanism was first systematically characterized by Tiina Karu at the Russian Academy of Sciences across three decades of work culminating in her 2010 IUBMB Life review (PMID 20681024), and has been continuously elaborated by Michael Hamblin at Harvard Medical School/Wellman Center.

PBM is the most mechanistically characterized and most extensively FDA-cleared of all the wavelength-based therapeutic modalities. The cytochrome c oxidase absorption peaks at 670 nm and 830 nm are well-mapped. The mitochondrial respiratory chain response (increased ATP synthesis, nitric oxide release, reactive oxygen species modulation, calcium signaling) is reproducibly demonstrated across in vitro, animal, and human studies.

The Tesla BioLights connection

The Tesla BioLights S.E.A.D. System emits broadband photonic energy across the 600-1100 nm optical window as a consequence of noble gas plasma physics. Argon, neon, xenon, and krypton — when ionized in the device's sealed glass tubes by the Tesla coil's ultra-high frequency drive — emit characteristic spectral lines that include the cytochrome c oxidase absorption bands. The mechanism by which Tesla BioLights produces its photonic component is identical to the PBM mechanism the peer-reviewed literature has been characterizing for 40 years.

The eight essays

Day 12 · Mechanism

Mitochondria as Light Antennae: Cytochrome c Oxidase Converts Photons Into ATP

The molecular mechanism. How CCO absorbs photons at 670 nm and 830 nm. The respiratory chain response. The Karu 2010 IUBMB Life canonical reference.

Day 13 · Wavelength Physics

The 600-1100 nm Optical Window: Why Red and Near-Infrared Light Heal

Why this specific wavelength band penetrates tissue. Hemoglobin and water absorption boundaries. The bio-window in vivo.

Day 1 · Biophoton Foundation

The Science of Biophotons: How Cells Communicate Through Light

The Popp ultraweak photon emission framework. How cells emit and absorb light at therapeutically relevant wavelengths.

Day 2 · Source Physics

Noble Gases, Plasma Light, and Why Tesla BioLights Picks Argon, Neon, Xenon, Krypton

The plasma spectrum. Why noble gas ionization produces a broadband emission that overlaps the cytochrome c oxidase absorption bands.

Day 23 · Session Physiology

How a 15-Minute Tesla BioLights Session Works, Bioelectrically

Minute-by-minute mapping of the photonic dose against the cellular response. The PBM mechanism in real time.

Day 18 · Measurement

HRV, Light, and PEMF: How to Actually Measure the Parasympathetic Dose

Heart rate variability as the objective biomarker for the autonomic response to PBM exposure. Lehrer-Gevirtz, McCraty, Shaffer.

Day 19 · Comparative Anatomy

Why Most Wellness Devices Aren't Tesla BioLights: A Comparative Anatomy

Where Tesla BioLights sits among Joovv, BEMER, BioCharger NG and other modalities — specifically on the PBM dimension.

Day 25 · Lineage Synthesis

The Lineage in One Image: 130 Years of Bioelectric Medicine, Tesla to Levin

PBM's place in the broader 130-year electromagnetic medicine lineage. Karu, Hamblin alongside Bassett, Pilla, Popp, Levin.

The PBM-specific citation stack

Karu TI. Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMB Life. 2010;62(8):607-610. PMID 20681024.
Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. 2017;4(3):337-361. PMC5523874.
Anders JJ, Lanzafame RJ, Arany PR. Low-level light/laser therapy versus photobiomodulation therapy. Photomed Laser Surg. 2015;33(4):183-184. PMID 25844681. (the terminology consensus paper)
de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22(3):7000417. PMID 28070154.
Hamblin MR. Photobiomodulation or low-level laser therapy. J Biophotonics. 2016;9(11-12):1122-1124. PMID 27973730.